Literature DB >> 11121410

A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemin2 on SMN.

J Wang1, G Dreyfuss.   

Abstract

The motor neuron degenerative disease spinal muscular atrophy is caused by reduced expression of the survival motor neuron (SMN) protein. Here we report a genetic system developed in the chicken pre-B cell line DT40, in which the endogenous SMN gene is disrupted by homologous recombination, and SMN protein is expressed from a chicken SMN cDNA under control of a tetracycline (tet)-repressible promoter. Addition of tet results in depletion of SMN protein and consequent cell death, which directly demonstrates that SMN is required for cell viability. The tet-induced lethality can be rescued by expression of human SMN, indicating that the function of SMN is highly conserved between the two species. Cells expressing low levels of SMN display slow growth proportional to the amount of SMN they contain. Interestingly, the level of the SMN-interacting protein Gemin2 decreases significantly following depletion of SMN, supporting the conclusion that SMN and Gemin2 form a stable complex in vivo. This system provides a powerful setting for studying the function of SMN in vivo and for screening for potential therapeutics for spinal muscular atrophy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121410     DOI: 10.1074/jbc.M009162200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Exploring biology with small organic molecules.

Authors:  Brent R Stockwell
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

2.  The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy.

Authors:  Lili Wan; Daniel J Battle; Jeongsik Yong; Amelie K Gubitz; Stephen J Kolb; Jin Wang; Gideon Dreyfuss
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  Stem cells: Tailor-made diseased neurons.

Authors:  Michael Sendtner
Journal:  Nature       Date:  2009-01-15       Impact factor: 49.962

4.  Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons.

Authors:  Honglai Zhang; Lei Xing; Wilfried Rossoll; Hynek Wichterle; Robert H Singer; Gary J Bassell
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

Review 5.  Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Authors:  Jonathan J Cherry; Dione T Kobayashi; Maureen M Lynes; Nikolai N Naryshkin; Francesco Danilo Tiziano; Phillip G Zaworski; Lee L Rubin; Jill Jarecki
Journal:  Assay Drug Dev Technol       Date:  2014-08       Impact factor: 1.738

6.  Conditional deletion of SMN in cell culture identifies functional SMN alleles.

Authors:  Anton J Blatnik; Vicki L McGovern; Thanh T Le; Chitra C Iyer; Brian K Kaspar; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-10-19       Impact factor: 6.150

7.  SMN deficiency reduces cellular ability to form stress granules, sensitizing cells to stress.

Authors:  Tie Zou; Xianming Yang; Danmin Pan; Jia Huang; Mustafa Sahin; Jianhua Zhou
Journal:  Cell Mol Neurobiol       Date:  2011-01-15       Impact factor: 5.046

8.  SMN interacts with a novel family of hnRNP and spliceosomal proteins.

Authors:  Z Mourelatos; L Abel; J Yong; N Kataoka; G Dreyfuss
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

9.  Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs.

Authors:  Peter Claus; Alexander-Francisco Bruns; Claudia Grothe
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

10.  Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent.

Authors:  Chia-Yen Wu; Ilsa Gómez-Curet; Vicky L Funanage; Mena Scavina; Wenlan Wang
Journal:  BMC Cell Biol       Date:  2009-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.